FDA issues complete response letter for Amyvid NDA: Eli Lilly, Avid
Avid, a wholly-owned subsidiary of Eli Lilly. Lilly acquired Avid Radiopharmaceuticals in December 2010. Amyvid is a molecular imaging agent under investigation for Positron Emission Tomography (PET) imaging
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.